QuickView for BTK;jsessionid=785291C527F752BB6752B91066028419 (gene)

1. New means and challenges in the targeting of BTK.
2. Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127.
3. Screening and Characterization of Allosteric Small Molecules Targeting Bruton's Tyrosine Kinase.
4. Bruton's Tyrosine Kinase Inhibitors: Recent Updates.
5. The effect of Bruton's tyrosine kinase (BTK) inhibitor in the eosinophilic asthma model of mouse.

There were no clinical trials for BTK;jsessionid=785291C527F752BB6752B91066028419